Ova, a UK-based brand dedicated to enhancing egg and sperm health, recently secured a significant boost of $1 million in pre-seed funding from Era VC, Ventures Together, Syndicate Room, and several angel investors, notably including industry veterans like Gemma Bellman and Lisa Gordon. This funding marks a promising step for Ova, which is gaining traction in the fertility space that continues to grow in both awareness and importance. The backing reflects a recognition of the brand’s innovative approach to a topic traditionally seen as a women’s issue, emphasizing the collaborative nature of fertility.
Since its launch just seven months ago, Ova has introduced a lineup of four distinct products tailored to support reproductive health. The brand’s flagship offerings include Ova Her, a supplement geared towards fertility and pregnancy, and Ova Him, designed to enhance sperm health. Accompanying these are Ova Plus, which aids hormonal balance, and Ova Omega, an omega-3 supplement that supports reproductive health. This range demonstrates Ova’s commitment to delivering science-backed solutions to a market that has often been overlooked.
Founders Danielle Fox-Thomas and Kat Lestage, both former Net-a-Porter executives, saw an opportunity to create Ova based on their personal experiences with fertility challenges. Both women found themselves navigating the often difficult path of conception while building their brand, bringing unique insights and passion to their business. Their journey reflects an authentic narrative—one of resilience and determination—that resonates deeply within the fertility community. “We basically created our own Ova babies while launching the brand,” shared Fox-Thomas, highlighting the intersection of their professional and personal endeavors.
As they traveled this challenging path, Fox-Thomas noted how their experiences helped attract the right investors. “We wanted investors who believed in our vision,” she explained, emphasizing the importance of authenticity in their brand’s messaging. The challenges they faced became a valuable talking point that connected them with like-minded individuals who understood the heart of their mission. They emphasized the need for a brand that speaks to contemporary consumers who are seeking straightforward, effective solutions without the stigma that often surrounds fertility discussions.
The response from retailers has been overwhelmingly positive, showcasing the demand for products in this burgeoning category. Ova’s contemporary branding and transparent messaging struck a chord with buyers, leading to partnerships with major retailers like Boots and Sainsbury’s, even before launching their direct-to-consumer operations. Fox-Thomas and Lestage noted how the funding has allowed them to avoid stock shortages as they expand their reach, including plans to enter the Irish market. Their collaboration with Boots has been particularly fruitful, demonstrating the appetite for innovative health products in traditional retail environments.
Looking ahead, Ova is preparing to diversify and expand its product offerings further. Initiatives are already underway to develop solutions supporting those grappling with symptoms of PMS, PCOS, and individuals transitioning off birth control. By addressing a wider range of reproductive health issues, Ova aims to solidify its position as a leader in fertility solutions. “One in four of us will face challenges related to fertility, and we want to provide actionable products that really help,” Fox-Thomas stated, reinforcing the brand’s commitment to making a positive impact in a field that affects many families. Their journey is not just about building a business, but also about empowering individuals navigating the complex landscape of reproductive health.
